Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 1 of 1
Date Title
17/05/2012 Protopic (tacrolimus) - Important Safety Information from Astellas Pharma Europe as approved by the Irish Medicines Board
20/04/2012 Protelos/Osseor (strontium ranelate) - Important safety information from Servier Laboratories (Ireland) as approved by the Irish Medicines Board
29/03/2012 Perfalgan (intravenous paracetamol) - Important Safety Information from Bristol-Myers Squibb as approved by the Irish Medicines Board
17/02/2012 Pradaxa (dabigatran etexilate) - Recommendations for assessment of renal function and monitoring in the elderly
04/11/2011 Pradaxa (dabigatran etexilate) - Important Safety Information from Boehringer Ingelheim as approved by the Irish Medicines Board
05/09/2011 Pioglitazone – New contra-indications and warnings following European review of bladder cancer risk
09/05/2011 Paracetamol and asthma in children
08/07/2010 PERFALGAN 10 mg/ml, solution for infusion - Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
19/04/2010 Palifermin (Kepivance) - Important Safety Information from Biovitrum as approved by the Irish Medicines Board
16/02/2010 Protopic - Important Safety Information from Astellas Pharma Co. Ltd. as approved by the Irish Medicines Board
15/02/2010 Publication of Field Safety Notices
05/08/2009 Potential Interaction of Proton Pump Inhibitors with Clopidogrel-containing medicines (Plavix) - Important Safety Information from sanofi-aventis Ireland Ltd. as approved by the Irish Medicines Board
02/12/2008 Prograf & Advagraf (tacrolimus)-Important Safety Information from Astellas Pharma following approval by the IMB
03/10/2008 Perfalgan (paracetamol)-Important Safety Notice from Bristol-Myers Squibb regarding hepatic toxicity
25/02/2008 Provigil (modafinil)-Important Safety Information from Cephalon as approved by the IMB
23/11/2007 Protelos (strontium ranelate)-important safety information from Servier as approved by the Irish Medicines Board
01/11/2006 Protocol Template for Investigator-Led Trials
Page 1 of 1



Date Printed: 19 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971